Articles Tagged: Stem Cells
July 16, 2014 | Category: News
| Spinal Cord Injury: C-2
PERRY Cross was just 19 when he suffered a devastating neck injury that should have killed him.
Doctors told his family he had months to live, and if he survived beyond that the best he could hope for as a quadriplegic was just 10 years.
Now almost 20 years later, Mr Cross is still cheating death after a rugby accident that left him unable to walk, talk, eat, move his head or even breathe without the help of a respirator. Continue Reading »
Robert Waddell says he’s glad the stem cells that healed him came from “a guy who was 50 years old” and not a human embryo.
As a Catholic, Waddell opposes the destruction of embryos and didn’t want to rely on embryonic stem cells to cure his kidney disease. But he avoided this moral dilemma by getting bone marrow stem cells from a friend who donated a kidney as part of a University of Louisville study.
“It has nothing to do with embryonic stem cells,” said Waddell, a 47-year-old father of four. “That made it a lot easier.” Continue Reading »
(CNN) — Here’s a look at what you need to know about stem cells.
Scientists believe that stem cell research can be used to treat medical conditions including Parkinson’s Disease, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis, and rheumatoid arthritis. Continue Reading »
While human embryonic stem cells (hESCs) were originally created in 1998, it wasn’t until 2009 — over a decade later — that they were approved by the FDA for use in a clinical trial in people. It was a long wait, but the trial was quite the promising one. The clinical trial, undertaken by the Geron Corporation, was for using hESCs to treat patients with spinal cord injuries and paralysis.
Very unfortunately, the trial became stalled in late 2011, mostly due to financial concerns (but it did undoubtedly help pave the way for other hESC-based clinical trials to get FDA approval starting in 2010). Continue Reading »
April 18, 2014 | Category: News
| Spinal Cord Injury: T-1
Neuralstem, announced that the Institutional Review Board of the University of California, San Diego, School of Medicine has approved the phase I safety trial to treat chronic spinal cord injury (cSCI) with its NSI-566 stem cells. The NSI-566/cSCI phase I trial will enroll patients with thoracic spinal cord injuries (T2-T12) who have an American Spinal Injury Association (AIS) A level of impairment, between one and two years after injury. AIS A impairment, which is complete paralysis, refers to a patient with no motor or sensory function in the relevant segments at and below the injury. Continue Reading »
April 10, 2014 | Category: News
LONDON, April 10, 2014 — Paralysis caused by a motor neuron disease or spinal cord injury understandably causes feelings of hopelessness, helplessness and despair. But there is optimism in a new technique that can artificially control paralyzed muscles using light.
The technique, developed at University College London and King’s College London could potentially restore the function of muscles afflicted by motor neuron disease or spinal cord injury. Continue Reading »
February 3, 2014 | Category: News
Previous studies have shown that multiple stem cell implantations might assist adults suffering from complete spinal cord injuries (SCI). Now a groundbreaking study released today in STEM CELLS Translational Medicine shows for the first time that children with SCI might benefit, too.
Marcin Majka, Ph.D., and Danuta Jarocha, Ph.D., led the study at Jagiellonian University College of Medicine in Krakow, Poland. “Although it was conducted on a small number of patients carrying a different injury level and type, preliminary results demonstrate the possibility of attaining neurological, motor and sensation and quality-of-life improvement in children with a chronic complete spinal cord injury through multiple bone marrow derived cell (BMNC) implantations. Intravenous implantations of these cells seem to prevent and/or help the healing of pressure ulcers,” Dr. Majka said. Continue Reading »
November 21, 2013 | Category: News
| Spinal Cord Injury: T-10
After laboratory mice received a contusive spinal cord injury at the T10 level, low and high doses of neural stem/progenitor cells (NS/PCs) derived from fetal bioluminescent-labeled transgenic mice were injected into four groups of mice at either the lesion epicenter or at rostral and caudal sites. A control group was similarly injected with phosphate buffered saline. The mice receiving the NS/PC cells experienced motor functional recovery while those in the control group did not.
It is known that transplanting neural stem/progenitor cells (NS/PCs) into the spinal cord promotes functional recovery after spinal cord injury (SCI). However, which transplantation sites provide optimal benefit? Continue Reading »
September 11, 2013 | Category: News
LONDON (Reuters) – Scientists have succeeded in generating new stem cells in living mice and say their success opens up possibilities for the regeneration of damaged tissue in people with conditions ranging from heart failure to spinal cord injury.
The researchers used the same “recipe” of growth-boosting ingredients normally used for making stem cells in a petri dish, but introduced them instead into living laboratory mice and found they were able to create so-called reprogrammed induced pluripotent stem cells (iPS cells). Continue Reading »
August 26, 2013 | Category: News
Washington, August 26 (ANI): Researchers have discovered a new technique called Biphasic Electrical stimulation (BES), a non-chemical procedure, that they believe can be used for spinal cord injury patients in the future.
Transplantation of Stem Cells is a potential clinical therapy for repair and regeneration of injured spinal cord, and brings new hope for patients. However, the survival rate of transplanted cells is relatively low as the cells are particularly vulnerable to apoptosis in the spinal cord. Continue Reading »